Pet owners report extreme alleged side effects from ‘miracle drug’ Librela for arthritic dogs
The Globe and Mail spoke with eight people whose pet’s health declined after taking Librela. Drugmaker Zoetis has responded ...
General Mills is buying its fifth pet-food business. Here’s why it could fetch more growth.
From an estimated $150 billion of spending in 2024, the category is expected to mushroom up to roughly $200 billion by 2030, ...
Business Insider19h
Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)
announced today that Health Canada has approved JORNAY PM™, an extended-release formulation of methylphenidate, a stimulant medication for the treatment of Attention-Deficit Hyperactivity Disorder ...